why choose us

First received: April 26, 2023

Clinical Trial: (2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Pain, Neuropathic

Study Type: INTERVENTIONAL


Official Title: (2R,6R)-Hydroxynorketamine a Novel Therapeutic Analgesic for the Treatment of Neuropathic Pain: A Randomized Double Blind Cross-Over Trial.

Brief Summary: The goal of this randomized double blind three way (1:1:1) cross over clinical trial is to evaluate the effectiveness and duration of analgesia of a single infusion of (2R,6R)-HNK 0.5mg/kg compared with ketamine 0.5mg/kg and saline with a 5-week interval between treatments on pain, pain qualities, physical function, pain interference, sleep disturbance and quality of life in subjects with neuropathic pain of the extremities.The questions that this study will address are:What is the analgesic efficacy of…

Read more